APA (7th ed.) Citation

JK, R., AC, C., BD, B., JP, B., R, S., A, S., . . . PA, N. (2025). Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [18F]-fluoroethoxybenzovesamicol positron emission tomography imaging. Neurobiology of aging, 148, 50. https://doi.org/10.1016/j.neurobiolaging.2025.01.008

Chicago Style (17th ed.) Citation

JK, Russell, et al. "Differences in Cholinergic Terminal Density in Adults with Down Syndrome Compared to Neurotypical Controls Measured by [18F]-fluoroethoxybenzovesamicol Positron Emission Tomography Imaging." Neurobiology of Aging 148 (2025): 50. https://doi.org/10.1016/j.neurobiolaging.2025.01.008.

MLA (9th ed.) Citation

JK, Russell, et al. "Differences in Cholinergic Terminal Density in Adults with Down Syndrome Compared to Neurotypical Controls Measured by [18F]-fluoroethoxybenzovesamicol Positron Emission Tomography Imaging." Neurobiology of Aging, vol. 148, 2025, p. 50, https://doi.org/10.1016/j.neurobiolaging.2025.01.008.